Yayın:
Nutritional aspect of cancer care in medical oncology patients

dc.contributor.authorYalçın, Şuayib
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorÖksüzoğlu, Berna
dc.contributor.authorÖzdemir, Feyyaz
dc.contributor.authorSarıoğlu, Aysugül Alptekin
dc.contributor.authorŞahin, Berksoy
dc.contributor.authorMandel, Nil Molinas
dc.contributor.authorGöker, Erdem
dc.contributor.buuauthorEvrensel, Türkkan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDahili Tıp Bilimleri
dc.contributor.departmentİç Hastalıkları Bölümü
dc.contributor.orcid0000-0002-9732-5340
dc.contributor.researcheridAAJ-1027-2021
dc.contributor.scopusid6603942124
dc.date.accessioned2023-06-15T05:55:36Z
dc.date.available2023-06-15T05:55:36Z
dc.date.issued2019-11
dc.description.abstractPurpose: Awareness of advances in the nutritional aspects of cancer care and translation of this information into clinical practice are important for oncology practitioners to effectively couple oncologic and nutritional approaches throughout the cancer journey. The goal of this consensus statement by a panel of medical oncologists was to provide practical and implementable guidance addressing nutritional aspects of cancer care from the perspective of the medical oncologist. Methods: A panel of medical oncologists agreed on a series of statements supported by scientific evidence and expert clinical opinion. Findings: Participating experts emphasized that both poor nutritional intake and metabolic alterations underlie cancer-related malnutrition. The use of liquid and high energy-dense oral nutritional supplements may enable better patient compliance, whereas higher efficacy is more likely with the use of pharmaconutrient-enriched oral nutritional supplements in terms of improved weight, lean body mass, functional status, and quality of life, as well as better tolerance to antineoplastic treatment. A multimodal approach is currently believed to be the best option to counteract the catabolism leading to cancer-related malnutrition; this treatment is scheduled in parallel with anticancer therapies and includes nutritional interventions, multitarget drug therapies, and exercise and rehabilitation programs. Participating experts emphasized the role of the oncologist as a reference professional figure in the coordination of nutritional care for patients with cancer within the context of complex and different clinical scenarios, particularly for permissive-adjunctive nutritional support.
dc.description.sponsorshipAbbott Türkiye
dc.identifier.citationYalçın, S. vd. (2019). ''Nutritional aspect of cancer care in medical oncology patients''. Clinical Therapeutics, 41(11), 2382-2396.
dc.identifier.doi10.1016/j.clinthera.2019.09.006
dc.identifier.endpage2396
dc.identifier.issn0149-2918
dc.identifier.issn1879-114X
dc.identifier.issue11
dc.identifier.pubmed31699437
dc.identifier.scopus2-s2.0-85074892538
dc.identifier.startpage2382
dc.identifier.urihttps://doi.org/10.1016/j.clinthera.2019.09.006
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0149291819304837
dc.identifier.urihttp://hdl.handle.net/11452/33040
dc.identifier.volume41
dc.identifier.wos000503107700016
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalClinical Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPharmacology & pharmacy
dc.subjectCancer cachexia
dc.subjectCancer patients
dc.subjectNutritional screening
dc.subjectNutritional support
dc.subjectMedical oncologist's perspective
dc.subjectTreatment
dc.subjectPreoperative oral supplementation
dc.subjectVitamin-D
dc.subjectEIcosapentaenoic acid
dc.subjectWeight-loss
dc.subjectCachexia
dc.subjectMalnutrition
dc.subjectGlutamine
dc.subjectRisk
dc.subjectExercise
dc.subjectTherapy
dc.subject.emtreeAmino acid
dc.subject.emtreeAntineoplastic agent
dc.subject.emtreeArginine
dc.subject.emtreeBeta hydroxy beta methylbutyrate
dc.subject.emtreeGlutamine
dc.subject.emtreeNutrition supplement
dc.subject.emtreeOmega 3 fatty acid
dc.subject.emtreeTrace element
dc.subject.emtreeUnclassified drug
dc.subject.emtreeBody mass
dc.subject.emtreeCachexia
dc.subject.emtreeCancer chemotherapy
dc.subject.emtreeCancer patient
dc.subject.emtreeDietary intake
dc.subject.emtreeExercise
dc.subject.emtreeFunctional status
dc.subject.emtreeHuman
dc.subject.emtreeMacronutrient
dc.subject.emtreeMalignant neoplasm
dc.subject.emtreeMalnutrition
dc.subject.emtreeMedical oncologist
dc.subject.emtreeNutrition
dc.subject.emtreeNutritional counseling
dc.subject.emtreeNutritional requirement
dc.subject.emtreeNutritional support
dc.subject.emtreeOncologist
dc.subject.emtreeOncology
dc.subject.emtreePathophysiology
dc.subject.emtreePatient care
dc.subject.emtreePatient compliance
dc.subject.emtreePatient monitoring
dc.subject.emtreePhysician attitude
dc.subject.emtreeQuality of life
dc.subject.emtreeReview
dc.subject.emtreeScreening
dc.subject.emtreeComplication
dc.subject.emtreeConsensus
dc.subject.emtreeMalnutrition
dc.subject.emtreeNeoplasm
dc.subject.emtreeOncology
dc.subject.meshConsensus
dc.subject.meshExercise
dc.subject.meshHumans
dc.subject.meshMalnutrition
dc.subject.meshMedical Oncology
dc.subject.meshNeoplasms
dc.subject.scopusCachexia; Skeletal Muscle; Muscle Atrophy
dc.subject.wosPharmacology & pharmacy
dc.titleNutritional aspect of cancer care in medical oncology patients
dc.typeArticle
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Dahili Tıp Bilimleri/İç Hastalıkları Bölümü
local.indexed.atPubMed
local.indexed.atWOS

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Türkkan_vd_2019.pdf
Boyut:
929.39 KB
Format:
Adobe Portable Document Format
Açıklama

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama